This survival difference was confirmed in the TCGA cohort, and low GR expression was also strongly correlated with poor DFS (5-DFS rates: 51% vs 87%, p = 0.015; Figure 5B) and OS (5-OS rates: 53% vs 88%, p = 0.012; Figure 5D) in ACC patients. This evidence concerns the gene NR3C1 and adrenal cortex carcinoma.